Symmetry Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-16,600
| Closed | -$1.58M | – | 242 |
|
2024
Q1 | $1.58M | Buy |
+16,600
| New | +$1.58M | 0.09% | 87 |
|
2023
Q4 | – | Sell |
-16,200
| Closed | -$1.18M | – | 217 |
|
2023
Q3 | $1.18M | Buy |
+16,200
| New | +$1.18M | 0.24% | 71 |
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$672K | – | 117 |
|
2021
Q4 | $672K | Buy |
+6,000
| New | +$672K | 0.21% | 53 |
|